High Outlier
Strength
.125 mg/1
Manufacturer
Pfizer Inc.NDC
00069580060
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/1/2018
Active Ingredients
DOFETILIDEApproval Type
New Drug (NDA)
FDA Application
NDA020931On Market Since
10/1/1999
Pharmacological Classes
Related Drugs
Same classification
XYLOCAINE 2%-EPI 1:100,000
Brand
63323048327•Fresenius Kabi USA, LLC
$0.2655
per ML
XYLOCAINE 1%-EPI 1:100,000
Brand
63323048226•Fresenius Kabi USA, LLC
$0.2721
per ML
XYLOCAINE 1%-EPI 1:100,000
Brand
63323048227•Fresenius Kabi USA, LLC
$0.2721
per ML
SOTYLIZE 5 MG/ML ORAL SOLUTION
Brand
24338053025•Azurity Pharmaceuticals Inc.
$2.3056
per ML
SOTYLIZE 5 MG/ML ORAL SOLUTION
Brand
24338053048•Azurity Pharmaceuticals Inc.
$2.3353
per ML
NORPACE CR 100 MG CAPSULE
Brand
00025273231•Pfizer Inc.
$4.1412
per EA
NORPACE CR 150 MG CAPSULE
Brand
00025274231•Pfizer Inc.
$4.9062
per EA
ZTLIDO 1.8% TOPICAL SYSTEM
Brand
69557011130•Scilex Pharmaceuticals Inc.
$12.3221
per EA
MULTAQ 400 MG TABLET
Brand
00024414260•Sanofi-Aventis U.S. LLC
$13.1941
per EA
NUEDEXTA 20-10 MG CAPSULE
Brand
59148005316•Otsuka America Pharmaceutical Inc.
$26.6488
per EA